NCT03758924 - Study of ANAVEX2-73 in Patients With Rett Syndrome | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2019

Primary Completion Date

October 30, 2020

Study Completion Date

October 30, 2020

Conditions

Rett Syndrome

Interventions

DRUG

ANAVEX2-73

Liquid oral solution

DRUG

Placebo

Liquid oral solution

Trial Locations (8)

Greenwood Genetic Center, Greenwood

Cincinnati Children's Hospital Medical Center, Cincinnati

Rush University Medical Center, Chicago

Baylor College of Medicine, Houston

UC Davis University of California - Davis MIND Institute, Sacramento

"UAB , The University of Alabama at Birmingham"

Boston Children's Hospital, Boston

"Washington University in St. Louis , Saint Louis Children's Hospital"